Xu, Haochen
Thomas, Marwa T.
Lee, Dayeong
Hirabayashi, Matthew T.
An, Jella A.
Article History
Received: 1 June 2021
Revised: 30 January 2022
Accepted: 21 February 2022
First Online: 11 March 2022
Declarations
:
: The study protocol (IRB #2014107) was approved by the University of Missouri Institutional Review Board, which granted a waiver of consent for retrospective analysis of existing health records. This study followed the tenets of the Declaration of Helsinki, and patient data were collected and maintained confidentially in compliance with the Health Insurance Portability and Accountability Act.
: N/A.
: N/A.
: J.A. is a consultant for Aerie Pharmaceuticals and New World Medical. All other authors have no conflicts of interest to declare that are relevant to the content of this article.